The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The US Food and Drug Administration approved using Wegovy in pill form to treat weight loss Starting dose to be available in ...

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Dec 23 () - The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo ...

Each year, millions of people turn to diet pills to lose weight. As of 2022, about 15 percent of U.S. adults reported using a weight-loss supplement at some point in their lives. One popular ...

Molecule, a pill promising rapid weight loss, went viral on Russian TikTok earlier this year. Young people's feeds started filling up with captions like "Take Molecule and forget food exists", and "Do ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug.